Vilin Bio Med Limited (NSE:VILINBIO)
India
· Delayed Price · Currency is INR 38.10
+0.70 (1.87%)
Apr 29, 2026, 1:14 PM IST
Vilin Bio Med Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Net Income | 2.51 | 2.24 | 1.62 | 12.45 | 0.34 | 1.21 | Upgrade
|
| Depreciation & Amortization | 1.05 | 1.04 | 1.3 | 1.68 | 2.19 | 2.57 | Upgrade
|
| Other Operating Activities | 2.62 | 3.92 | 4.73 | -0 | 0.01 | -0 | Upgrade
|
| Change in Accounts Receivable | 11.95 | -6.22 | -0.84 | -20.87 | -1.41 | -3.76 | Upgrade
|
| Change in Inventory | -20.16 | 0.56 | -35.89 | 14.05 | -2.2 | 0.45 | Upgrade
|
| Change in Accounts Payable | -7.56 | -5.65 | 7.64 | 5.48 | -1.76 | -10.44 | Upgrade
|
| Change in Other Net Operating Assets | 8.61 | 6.28 | -52.79 | -29.37 | 4.91 | -0.06 | Upgrade
|
| Operating Cash Flow | -0.99 | 2.18 | -74.21 | -16.59 | 2.09 | -10.02 | Upgrade
|
| Capital Expenditures | -16.56 | -15.75 | -0.01 | -0.3 | - | - | Upgrade
|
| Other Investing Activities | 2.49 | 4.66 | 3.24 | - | - | - | Upgrade
|
| Investing Cash Flow | -14.07 | -11.09 | 3.23 | -0.3 | - | - | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 0.66 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 10.16 | Upgrade
|
| Total Debt Issued | - | - | - | - | 0.66 | 10.16 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -0.34 | Upgrade
|
| Long-Term Debt Repaid | - | -42.57 | -23.44 | -3.57 | -2.82 | - | Upgrade
|
| Total Debt Repaid | -40.48 | -42.57 | -23.44 | -3.57 | -2.82 | -0.34 | Upgrade
|
| Net Debt Issued (Repaid) | -40.48 | -42.57 | -23.44 | -3.57 | -2.16 | 9.82 | Upgrade
|
| Issuance of Common Stock | - | - | 120 | 20.4 | - | - | Upgrade
|
| Other Financing Activities | -5.04 | -8.45 | -7.86 | - | - | - | Upgrade
|
| Financing Cash Flow | -45.51 | -51.02 | 88.71 | 16.84 | -2.16 | 9.82 | Upgrade
|
| Net Cash Flow | -60.57 | -59.93 | 17.73 | -0.05 | -0.08 | -0.2 | Upgrade
|
| Free Cash Flow | -17.55 | -13.57 | -74.22 | -16.88 | 2.09 | -10.02 | Upgrade
|
| Free Cash Flow Margin | -8.78% | -9.16% | -46.96% | -13.68% | 1.86% | -8.55% | Upgrade
|
| Free Cash Flow Per Share | -1.26 | -0.97 | -5.32 | -1.70 | 0.25 | -1.21 | Upgrade
|
| Cash Interest Paid | 5.04 | 8.45 | 7.86 | - | - | - | Upgrade
|
| Cash Income Tax Paid | 0.87 | 0.7 | 0.51 | 5.37 | -0.1 | 0.4 | Upgrade
|
| Levered Free Cash Flow | -26.98 | -21.66 | -38.21 | 62.94 | 1.6 | -10.05 | Upgrade
|
| Unlevered Free Cash Flow | -23.83 | -16.38 | -33.33 | 66.99 | 4.7 | -7.46 | Upgrade
|
| Change in Working Capital | -7.16 | -5.03 | -81.87 | -30.71 | -0.45 | -13.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.